Drug Type Gene therapy |
Synonyms |
Target |
Mechanism A1AT replacements(Alpha-1-antiproteinase replacements) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alpha 1-Antitrypsin Deficiency | Discovery | US | 15 Aug 2022 |